Rosner Elimelech
EVP, CHIEF TECHNOLOGY OFFICER
Rosner Elimelech has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Apr 8, 2026.
On the most recent filing, Rosner Elimelech is listed as EVP, CHIEF TECHNOLOGY OFFICER at HEALTHEQUITY, INC. Inside the rolling window, Rosner Elimelech reported no open-market purchases and 1 open-market sale totaling $1.0M in HQY.
Companies traded
Other insiders at HQY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rosner Elimelech made?
Rosner Elimelech has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Rosner Elimelech trade?
Rosner Elimelech has filed SEC Form 4 disclosures for 1 company, including HQY.
When was Rosner Elimelech's most recent SEC Form 4 filing?
Rosner Elimelech's most recent SEC Form 4 filing on Tracefour is dated Apr 8, 2026.
What is Rosner Elimelech's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rosner Elimelech is listed as EVP, CHIEF TECHNOLOGY OFFICER.
What is Rosner Elimelech's total buy and sell value in the current window?
Inside the rolling retention window, Rosner Elimelech bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Rosner Elimelech's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,959 HQY shares on 2025-12-18, worth $1.0M, per SEC Form 4 filings.